Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
Naples Comprehensive Health is building up what it hopes will be a nationally recognized cardiology program. Robert Cubeddu, MD, and Dee Dee Wang, MD, spoke with Cardiovascular Business about the journey so far.
The initiative is designed to help identify more patients who may require aortic valve replacement. Brian Lindman, MD, provided an update on the project's efforts.
Laxmi Mehta, MD, explained that the use of statins when treating pregnant women is no longer forbidden. However, she added, cardiologists should always discuss it first with their patients.
Suhny Abbara, MD, editor of Radiology: Cardiothoracic Imaging and chief of cardiothoracic imaging for University of Texas Southwestern Medical Center, discusses how spectral computed tomography (CT) can help both cardiac and general CT imaging.
Deepak Bhatt, MD, MPH, details long-term outcomes from the SYMPLICITY HTN-3 trial, which show a lasting impact on patients with uncontrolled hypertension.
Ed Nicol, MD, MBA, president-elect of the Society of Cardiovascular Computed Tomography, discusses what he sees as the big technology advances in cardiac CT.
Leslee Shaw, PhD, director of the Blavatnik Family Women's Health Research Institute, a professor of medicine at the Icahn School of Medicine at Mount Sinai, and a former president of both SCCT and ASNC, explains the sex differences in cardiovascular imaging presentations in women versus men.
Ricardo Cury, MD, chairman of radiology and director of cardiac imaging, Baptist Health South Florida and Miami Cardiac and Vascular Institute, discusses the new CAD-RADS 2.0 cardiac imaging reporting criteria.
Ed Nicol, MD, president-elect of the Society of Cardiovascular Computed Tomography, provided us with an exclusive look at how AI is expected to change cardiac imaging.
Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care.
Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.
